283 filings
8-K
SLS
SELLAS Life Sciences Group Inc
28 Mar 24
SELLAS Life Sciences Reports Full Year 2023 Financial Results and Provides Corporate Update
4:08pm
8-K
SLS
SELLAS Life Sciences Group Inc
28 Mar 24
Other Events
8:45am
8-K
SLS
SELLAS Life Sciences Group Inc
15 Mar 24
SELLAS Life Sciences Group Announces $20 Million Registered Direct Offering and Concurrent Private Placement Priced At-the-Market Under Nasdaq Rules
4:29pm
8-K
SLS
SELLAS Life Sciences Group Inc
11 Mar 24
Other Events
4:05pm
8-K
SLS
SELLAS Life Sciences Group Inc
8 Mar 24
SELLAS Announces Executive Leadership Reorganization and Prioritization of Commercialization Partnerships
4:05pm
8-K
xmnj9nejab54j
5 Mar 24
Other Events
4:01pm
8-K
lqhs8xz
16 Feb 24
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:05pm
8-K
qyulr8gl9s 1uc
8 Jan 24
SELLAS Life Sciences Announces Pricing of $9.0 Million Public Offering
5:07pm
8-K
dtho z6zd
3 Jan 24
Termination of a Material Definitive Agreement
5:25pm
8-K
utjq4o15 v69dq23
22 Dec 23
Other Events
9:05am
8-K
5p9d2uy7oxmbw4
13 Dec 23
Entry into a Material Definitive Agreement
4:21pm
8-K
x5xgdq 59c3psnkm8
8 Dec 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:05pm
8-K
4lbsffjq4si h6ksi
9 Nov 23
SELLAS Life Sciences Provides Business Update and Reports Third Quarter 2023 Financial Results
4:07pm
8-K
vuyuh
31 Oct 23
SELLAS Life Sciences Announces $4 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
8:11am
8-K
2392btz
16 Oct 23
SELLAS Announces Positive Initial Topline Phase 2a Data of SLS009 in Acute Myeloid Leukemia
8:51am
8-K
6k7yy9bmsa
13 Oct 23
SELLAS Life Sciences Provides Update on Phase 3 REGAL Clinical Trial for Galinpepimut-S in Acute Myeloid Leukemia
8:29am
8-K
ikirmry z0
10 Aug 23
SELLAS Life Sciences Provides Business Update and Reports Second Quarter 2023 Financial Results
4:12pm
8-K
doplgy fr5nq
20 Jun 23
Submission of Matters to a Vote of Security Holders
5:55pm
8-K
3ceo7p
1 Jun 23
Regulation FD Disclosure
4:11pm
8-K
y7ubhb
11 May 23
SELLAS Life Sciences Provides Business Update and Reports First Quarter 2023 Financial Results
4:16pm